Mark Massaro
Stock Analyst at BTIG
(4.34)
# 1,331
Out of 4,993 analysts
1043
Total ratings
41.1%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | $5 | $7.88 | -36.55% | 28 | Sep 4, 2026 | |
| GH Guardant Health | Reiterated: Buy | $195 | $179.38 | +8.71% | 50 | Sep 1, 2026 | |
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.19 | - | 30 | Aug 24, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $4 → $2 | $0.63 | +217.46% | 15 | Aug 21, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $70 → $80 | $77.84 | +2.77% | 12 | Aug 20, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $4.03 | - | 24 | Aug 18, 2026 | |
| FRNM Freenome | Initiated Coverage: Buy | $17 | $17.11 | -0.64% | 1 | Aug 17, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $2.5 | $0.7857 | +218.19% | 25 | Aug 17, 2026 | |
| CERS Cerus | Reiterated: Buy | $4 | $2.65 | +50.94% | 25 | Aug 14, 2026 | |
| TKNO Alpha Teknova | Upgraded: Buy | $8 | $7.79 | +2.70% | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $33 | $29.98 | +10.07% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $320 | $369.39 | -13.37% | 80 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 → $130 | $105.92 | +22.73% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $60 | $53.83 | +11.46% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $8.19 | +9.89% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $8.41 | +7.02% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $101.10 | -10.98% | 37 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $35.34 | +24.50% | 35 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $28.61 | -12.62% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $19.91 | - | 35 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $16 | $16.40 | -0.91% | 38 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $71.40 | +124.09% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $511.65 | +56.36% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.73 | n/a | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $4.15 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0006 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $10.62 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $3.56 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $3.07 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $310 | $239.62 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $173 → $170 | $320.71 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $113 | $246.45 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.25 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $23.75 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $149 → $145 | $180.94 | n/a | 2 | May 7, 2015 |
Ginkgo Bioworks Holdings
Sep 4, 2026
Reiterated: Sell
Price Target: $5
Current: $7.88
Upside: -36.55%
Guardant Health
Sep 1, 2026
Reiterated: Buy
Price Target: $195
Current: $179.38
Upside: +8.71%
MaxCyte
Aug 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.19
Upside: -
MDxHealth
Aug 21, 2026
Reiterated: Buy
Price Target: $4 → $2
Current: $0.63
Upside: +217.46%
Tempus AI
Aug 20, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $77.84
Upside: +2.77%
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.03
Upside: -
Freenome
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $17.11
Upside: -0.64%
Lucid Diagnostics
Aug 17, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.7857
Upside: +218.19%
Cerus
Aug 14, 2026
Reiterated: Buy
Price Target: $4
Current: $2.65
Upside: +50.94%
Alpha Teknova
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $7.79
Upside: +2.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $29.98
Upside: +10.07%
Aug 7, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $369.39
Upside: -13.37%
Aug 6, 2026
Reiterated: Buy
Price Target: $142 → $130
Current: $105.92
Upside: +22.73%
Aug 6, 2026
Reiterated: Buy
Price Target: $45 → $60
Current: $53.83
Upside: +11.46%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.19
Upside: +9.89%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.41
Upside: +7.02%
Aug 4, 2026
Reiterated: Buy
Price Target: $90
Current: $101.10
Upside: -10.98%
Aug 3, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $35.34
Upside: +24.50%
Jul 30, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $28.61
Upside: -12.62%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $19.91
Upside: -
Jul 20, 2026
Reiterated: Buy
Price Target: $11 → $16
Current: $16.40
Upside: -0.91%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $71.40
Upside: +124.09%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $511.65
Upside: +56.36%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.73
Upside: n/a
May 20, 2024
Reiterated: Buy
Price Target: $2
Current: $4.15
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0006
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Nov 17, 2019
Reiterated: Buy
Price Target: $70 → $75
Current: $10.62
Upside: n/a
Nov 10, 2019
Reiterated: Hold
Price Target: $7 → $8
Current: $3.56
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $35
Current: $3.07
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $300 → $310
Current: $239.62
Upside: n/a
Oct 24, 2019
Reiterated: Hold
Price Target: $173 → $170
Current: $320.71
Upside: n/a
Oct 22, 2019
Reiterated: Buy
Price Target: $112 → $113
Current: $246.45
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.25
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $23.75
Upside: n/a
May 7, 2015
Reiterated: Hold
Price Target: $149 → $145
Current: $180.94
Upside: n/a